Не сдохни! Еда в борьбе за жизнь

^{‹‹4››.} Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: U.S. Department of Health and Human Services; 2014.

^{‹‹5››.} Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).

^{‹‹6››.} 2014 Statistics Report. Centers for Disease Control and Prevention. http://www.cdc.gov/diabetes/data/ statistics/2014StatisticsReport.html. Updated October 24, 2014. Accessed March 3, 2015.

^{‹‹7››.} Lempainen J, Tauriainen S, Vaarala O, et al. Interaction of enterovirus infection and cow’s milkbased formula nutrition in type 1 diabetes-associated autoimmunity. Diabetes Metab Res Rev. 2012;28(2):177–85.

^{‹‹8››.} 2014 Statistics Report. Centers for Disease Control and Prevention. http://www.cdc.gov/diabetes/data/ statistics/2014StatisticsReport.html. Updated October 24, 2014. Accessed March 3, 2015.

^{‹‹9››.} Rachek LI. Free fatty acids and skeletal muscle insulin resistance. Prog Mol Biol Transl Sci. 2014;121:267–92.

^{‹‹10››.} 2014 Statistics Report. Centers for Disease Control and Prevention. http://www.cdc.gov/diabetes/data/ statistics/2014StatisticsReport.html. Updated October 24, 2014. Accessed March 3, 2015.

^{‹‹11››.} Sweeney JS. Dietary factors that influence the dextrose tolerance test. Arch Intern Med. 1927; 40(6):818–30.

^{‹‹12››.} Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996;97(12):2859–65.

^{‹‹13››.} Roden M, Krssak M, Stingl H, et al. Rapid impairment of skeletal muscle glucose transport/ phosphorylation by free fatty acids in humans. Diabetes. 1999;48(2):358–64.

^{‹‹14››.} Santomauro AT, Boden G, Silva ME, et al. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes. 1999;48(9):1836–41.

^{‹‹15››.} Krssak M, Falk Petersen K, Dresner A, et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia. 1999;42(1): 113–6.

^{‹‹16››.} Lee S, Boesch C, Kuk JL, Arslanian S. Effects of an overnight intravenous lipid infusion on intramyocellular lipid content and insulin sensitivity in African-American versus Caucasian adolescents. Metab Clin Exp. 2013;62(3):417–23.

^{‹‹17››.} Roden M, Krssak M, Stingl H, et al. Rapid impairment of skeletal muscle glucose transport/ phosphorylation by free fatty acids in humans. Diabetes. 1999;48(2):358–64.

^{‹‹18››.} Himsworth HP. Dietetic factors influencing the glucose tolerance and the activity of insulin. J Physiol (Lond). 1934;81(1):29–48.

^{‹‹19››.} Tabák AG1, Herder C, Rathmann W, Brunner EJ, Kivimáki M. Prediabetes: a high-risk state for diabetes. Lancet. 2012;379(9833):2279–90.

^{‹‹20››.} Pratley RE. The early treatment of type 2 diabetes. Am J Med. 2013;126(9 Suppl 1):S2–9.

^{‹‹21››.} Reinehr T. Type 2 diabetes mellitus in children and adolescents. World J Diabetes. 2013; 4(6):270–81.

^{‹‹22››.} Pihoker C, Scott CR, Lensing SY, Cradock MM, Smith J. Non-insulin dependent diabetes mellitus in African-American youths of Arkansas. Clin Pediatr (Phila). 1998;37(2):97–102.

^{‹‹23››.} Dean H, Flett B. Natural history of type 2 diabetes diagnosed in childhood: long term follow-up in young adult years. Diabetes. 2002;51(s1):A24.